Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-directed Immunotherapy of Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2017.257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells Through Increased McL-1 Proteasomal Degradation

Clinical Cancer Research
Cancer ResearchOncology
2017English

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

mTOR Signaling Is Activated by FLT3 Kinase and Promotes Survival of FLT3-mutated Acute Myeloid Leukemia Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Synergistic Cell Death in FLT3-ITD Positive Acute Myeloid Leukemia by Combined Treatment With Metformin and 6-Benzylthioinosine

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Prevalence of FMS-like Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD+) in De Novo Acute Myeloid Leukemia Patients Categorized According to Cytogenetic Risk

Sao Paulo Medical Journal
Medicine
2009English

Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy